vTv Therapeutics (VTVT) FCF Margin (2014 - 2026)

vTv Therapeutics (VTVT) posted FCF Margin of 24.85% for Q1 2026, up 100.09% sequentially from 28200.0% in Q4 2024.

vTv Therapeutics (VTVT) FCF Margin (2014 - 2026) Analysis & Trends

vTv Therapeutics has reported FCF Margin for 11 years, with the latest figure at 24.85% in Q1 2026.

Quarterly FCF Margin changed N/A year-over-year to 24.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.02% (up 13841316.0% YoY) and the FY2024 annual result came in at 2476.7%, changed N/A from the prior year.
FCF Margin climbed to 24.85% in Q1 2026 per VTVT's latest filing, from 28200.0% in the prior quarter.
Over five years, FCF Margin peaked at 7844.44% in Q2 2022 and troughed at 76444.44% in Q4 2022.
A 3-year average of 16259.48% and a median of 390.88% in 2022 frame the typical range for FCF Margin.
The widest YoY moves for FCF Margin: up 5226667 bps in 2022, down 514444 bps in 2022.
Over 3 years, FCF Margin stood at 76444.44% in 2022, then soared by 63 bps to 28200.0% in 2024, then surged by 100 bps to 24.85% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 24.85%, 28200.0%, and 730.7% for Q1 2026, Q4 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	30.39%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	13.35%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.68%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-77,594.17%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	70.82%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	22.62%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-22.35%
10	vTv Therapeutics	373.77 Mn	373.77 Mn	-	-

Download Data